# FDA Inspection 1307066 - Danbury Hospital, BB - February 26, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/danbury-hospital-bb/65735576-04f1-4d25-bab2-6525318b5dd6
Source feed: FDA_Inspections

> FDA Inspection 1307066 for Danbury Hospital, BB on February 26, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307066
- Company Name: Danbury Hospital, BB
- Inspection Date: 2026-02-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1307066 - 2026-02-26](https://www.globalkeysolutions.net/records/fda_inspections/danbury-hospital-bb/9cb2b320-1e07-4c87-9482-98474fa13be7)
- [FDA Inspection 957252 - 2016-01-27](https://www.globalkeysolutions.net/records/fda_inspections/danbury-hospital-bb/35add9cf-aa4b-4948-bdcd-2dad4de31ac4)
- [FDA Inspection 867595 - 2014-02-24](https://www.globalkeysolutions.net/records/fda_inspections/danbury-hospital-bb/a2067f76-95a3-426f-ba7d-c1a2005bda0a)
- [FDA Inspection 785114 - 2012-06-05](https://www.globalkeysolutions.net/records/fda_inspections/danbury-hospital-bb/41b610a3-d627-4eab-a22d-1e09e904d1ed)
- [FDA Inspection 675117 - 2010-08-09](https://www.globalkeysolutions.net/records/fda_inspections/danbury-hospital-bb/d986e7b3-6898-4121-a3c0-c2020f50bd9d)

Company: https://www.globalkeysolutions.net/companies/danbury-hospital-bb/bb096be9-1823-4bee-a035-2044b65ee434

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d